يعرض 1 - 20 نتائج من 4,735 نتيجة بحث عن '(((( via ((a decrease) OR (point decrease)) ) OR ( a linear decrease ))) OR ( _ parp decrease ))', وقت الاستعلام: 0.47s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Overview of study procedures. حسب Matthew G. Vinson (22593374)

    منشور في 2025
    "…Participants (n = 425) were randomized to either view an electronically-administered educational video informed by the COM-B behavioral change model (VIDEO, n = 223) or the FDA Drug Facts label for NSAIDs (CONTROL, n = 202). Intent to decrease OTC NSAIDs was evaluated via 11-point contemplation ladder immediately and 4 weeks post-intervention, with self-reported NSAID Exposure assessed at 4 weeks. …"
  8. 8
  9. 9
  10. 10

    The results of linear mixed model. حسب Soheila Qanbari (20455173)

    منشور في 2024
    "…The tDCS group demonstrated a significant decrease in AMT of MF and TrA/IO muscles (P < 0.05) and an increase in N80 amplitude (P = 0.027), with no significant changes in the control group. …"
  11. 11

    Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

    منشور في 2025
    "…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …"
  12. 12
  13. 13

    Table 1_PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation.xlsx حسب Nevena Grdović (394542)

    منشور في 2025
    "…Treatment of A549 cells with niraparib resulted in decreased PARP activity, increased 5hmC level, and synergism with cisplatin by promoting cisplatin-induced apoptosis. …"
  14. 14

    Data Sheet 1_PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation.pdf حسب Nevena Grdović (394542)

    منشور في 2025
    "…Treatment of A549 cells with niraparib resulted in decreased PARP activity, increased 5hmC level, and synergism with cisplatin by promoting cisplatin-induced apoptosis. …"
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20